# Biomat USA Inc – FDA Inspection, Jul 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/fbec913a-a6fb-4391-a4cc-6d977cd24933
Source feed: FDA_Inspections

> FDA inspection 1059746 of Biomat USA Inc, July 20, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 606. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1059746
- Company Name: Biomat USA Inc
- Inspection Date: 2018-07-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1233249 - 2024-02-22
- FDA Inspection 1028540 - 2017-07-26
- [FDA Inspection 818852 - 2013-02-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7a014745-aa10-4230-ae85-ef8937230b15)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/gloria-a-milster/22f95276-6f68-467d-8d52-5c028c118123)

Company: https://www.keypedia.com/companies/biomat-usa-inc/9d1438d7-64db-46c9-a3da-692f1de07360

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d